The role of alloreactive cytotoxic and lymphokine-secreting T lymphocytes in the development of acute graft-versus-host disease

Kaminski, 1988, Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation, Transplantation, 48, 608 DeGast, 1992, Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia, Bone Marrow Transpl, 9, 87 Delmonte, 1982, In vitro model for detection of alloreactivity between HLA-matched donor-host pairs: preliminary evaluation as a predictor of graft-versus-host disease, Transplantation, 34, 100, 10.1097/00007890-198208000-00009 Vogelsang, 1985, An in vitro predictive test for graft versus host disease in patients with genotypically HLA-identical bone marrow transplants, N Engl J Med, 313, 645, 10.1056/NEJM198509123131101 Sviland, 1990, An in vitro predictive test for clinical graft versus host disease in allogeneic bone marrow transplant recipients, Bone Marrow Transpl, 5, 105 Bagot, 1986, A possible predictive test for graft-versus-host disease in bone marrow graft recipients: The mixed-epidermal cell-lymphocyte reaction, Transplantation, 41, 316, 10.1097/00007890-198603000-00007 Bagot, 1988, The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients, Br J Haematol, 70, 403, 10.1111/j.1365-2141.1988.tb02508.x Johnsen, 1992, Donor alloreactivity may predict acute graft-versus-host disease in patients receiving marow transplants from HLA identical siblings, Bone Marrow Transpl, 9, 91 Johnsen, 1992, A study of donor alloreactivity, which may predict acute graft-versus-host disease in HLA identical bone marrow transplantations for early leukaemia, Scand J Immunol, 35, 353, 10.1111/j.1365-3083.1992.tb02868.x Johnsen, 1992, Donor alloreactivity may predict acute graft-versus-host disease in HLA-matched bone marrow transplantation for leukemia in early remission, Eur J Haematol, 48, 249, 10.1111/j.1600-0609.1992.tb01802.x Theobald, 1993, Pretransplant detection of human minor histocompatibility antigen-specific naive and memory interleukin-2-secreting T cells within class I major histocompatibility complex (MHC)-restricted CD8+ and class II MHC-restricted CD4+T-cell subsets, Blood, 82, 298, 10.1182/blood.V82.1.298.bloodjournal821298 Theobald, 1992, Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings, N Engl J Med, 327, 1613, 10.1056/NEJM199212033272301 Schwarer, 1993, Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood after HLA-identical sibling bone-marrow transplantation, Lancet, 341, 203, 10.1016/0140-6736(93)90067-Q Sprent, 1988, Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I-different hosts, J Exp Med, 167, 556, 10.1084/jem.167.2.556 Sprent, 1990, Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD, J Immunol, 144, 2946 Korngold, 1982, Features of T cells causing H-2 restricted lethal graft-vs-host disease across minor histocompatibility barriers, J Exp Med, 155, 872, 10.1084/jem.155.3.872 Korngold, 1983, Lethal GVHD across minor histocompatibility barriers: Nature of the effector cells and role of the H-2 complex, Immunol Rev, 71, 5, 10.1111/j.1600-065X.1983.tb01066.x Korngold, 1987, Variable capacity of L3T4+ T cells to cause graft-versus-host disease across minor histocompatibility barriers in mice, J Exp Med, 165, 1552, 10.1084/jem.165.6.1552 Champlin, 1990, Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation, Blood, 76, 418, 10.1182/blood.V76.2.418.418 Hamilton, 1987, L3T4-positive T cells participate in the induction of graft-versus-host disease in response to minor histocompatibility antigens, J Immunol, 139, 2511 Goulmy, 1988, Minor histocompatibility antigens in man and their role in transplantation, vol. 2, 29 De Bueger, 1991, Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes show variable expression on human skin cells, Eur J Immunol, 21, 2839, 10.1002/eji.1830211127 Niederwieser, 1993, Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens, Blood, 81, 2200, 10.1182/blood.V81.8.2200.2200 Tsoi, 1980, Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease, J Immunol, 125, 2258 Goulmy, 1983, A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft versus host disease, Nature, 302, 159, 10.1038/302159a0 Tsoi, 1983, Anti-host cytotoxic cells in patients with acute graft-versus-host disease after HLA-identical marrow grafting, Transpl Proc, 15, 1484 Irle, 1985, Alloreactive T cell responses between HLA-identical siblings, Transplantation, 40, 329, 10.1097/00007890-198509000-00021 De Bueger, 1992, Acquired tolerance for minor histocompatibility antigens after HLA identical bone marrow transplantation, Int Immunol, 4, 53, 10.1093/intimm/4.1.53 Irschick, 1992, Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies, Blood, 79, 1622, 10.1182/blood.V79.6.1622.1622 Kasten-Sportes, 1989, Phenotype and function of T lymphocytes infiltrating the skin during graft-versus-host disease following allogeneic bone marrow transplantation, Transplantation, 47, 621, 10.1097/00007890-198904000-00012 Van Els, 1990, Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigen. I. Absence of correlation with cytotoxic effector cells, Transplantation, 50, 62, 10.1097/00007890-199007000-00011 De Bueger, 1993, High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD, Bone Marrow Transpl, 11, 363 Hamilton, 1984, Absence of correlation between cytotoxic T lymphocytes and lethal murine GvHD in response to minor histocompatibility antigens, Transplantation, 38, 357, 10.1097/00007890-198410000-00009 Fontaine, 1991, Evaluation of in vitro CTL assays as a predictive test for the occurrence of graft vs host disease, Immunogenetics, 34, 222, 10.1007/BF00215256 Reinsmoen, 1984, Detection of HLA-restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions, Hum Immunol, 11, 249, 10.1016/0198-8859(84)90064-8 Irle, 1987, Detection of anti non-MHC directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures, Transpl Proc, 19, 2674 Van Els, 1990, Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules, Bone Marrow Transpl, 5, 365 Van Els, 1990, Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. II. Evidence of a possible involvement of proliferative T cells, Transplantation, 50, 67, 10.1097/00007890-199007000-00012 De Bueger, 1993, Human keratinocytes activate primed major and minor histocompatibility antigen specific Th cells in vitro, Transpl Immunol, 1, 52, 10.1016/0966-3274(93)90059-H Nierle, 1993, Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation, Blood, 81, 841, 10.1182/blood.V81.3.841.841 Lehmann, 1990, Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones, J Exp Med, 171, 1485, 10.1084/jem.171.5.1485 Dickinson, 1991, Demonstration of direct involvement of cytokine in graft versus host reactions using an in vitro human skin explant model, Bone Marrow Transpl, 7, 209 Cleveland MG, Annable CR, Klimpel GR: In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease. J Immunol 3988; 141: 3349–3356. Niederwieser, 1990, Endogenous IFN-gamma during human bone marrow transplantation: Analysis of serum levels of interferon and interferondependent secondary messages, Transplantation, 50, 620, 10.1097/00007890-199010000-00019 Piguet, 1987, Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease, J Exp Med, 166, 1280, 10.1084/jem.166.5.1280 Holler, 1990, Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation, Blood, 75, 1011, 10.1182/blood.V75.4.1011.1011 Symington, 1990, Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans, Transplantation, 50, 518, 10.1097/00007890-199009000-00033 McCarthy, 1991, Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease, Blood, 78, 1915, 10.1182/blood.V78.8.1915.1915 Antin, 1992, Cytokine dysregulation and acute graft-versus-host disease, Blood, 80, 2964, 10.1182/blood.V80.12.2964.2964 Mosmann, 1989, Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties, A Rev Immunol, 7, 145, 10.1146/annurev.iy.07.040189.001045 Salgame, 1991, Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones, Science, 254, 279, 10.1126/science.1681588 Palliard, 1988, Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones, J Immunol, 141, 849, 10.4049/jimmunol.141.3.849 Fong, 1990, Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines, J Immunol, 144, 1744, 10.4049/jimmunol.144.5.1744 Numerof, 1988, Interleukin 2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells, J Immunol, 141, 4250, 10.4049/jimmunol.141.12.4250 Aulitzky, 1991, Recombinant tumor necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: A phase I trial, Eur J Cancer, 27, 462, 10.1016/0277-5379(91)90387-S Steinman, 1991, The dendritic cell system and its role in immunogenicity, A Rev Immunol, 9, 271, 10.1146/annurev.iy.09.040191.001415 Niederwieser, 1988, IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses, J Immunol, 140, 2556, 10.4049/jimmunol.140.8.2556 Basham, 1984, IFN gamma induces HLADR on cultured human keratinocytes, J Invest Dermatol, 83, 88, 10.1111/1523-1747.ep12262597 Sviland, 1988, Class II antigen expression by keratinocytes and enterocytes is an early feature of graft versus host disease, Transplantation, 46, 402, 10.1097/00007890-198809000-00013